Search hospitals > Colorado > Littleton
UCHealth Highlands Ranch Hospital
Claim this profileLittleton, Colorado 80129
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
45 reported clinical trials
23 medical researchers
Summary
UCHealth Highlands Ranch Hospital is a medical facility located in Littleton, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. UCHealth Highlands Ranch Hospital is involved with conducting 45 clinical trials across 78 conditions. There are 23 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Anthony D Elias, M.D., and Christopher H. Lieu.Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Bradley R. CorrUniversity of Colorado Hospital1 year of reported clinical research
Studies Ovarian Cancer
Studies Cancer
20 reported clinical trials
33 drugs studied
Jose M. PachecoUniversity of Colorado Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
17 reported clinical trials
30 drugs studied
Anthony D Elias, M.D.University of Colorado3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
12 reported clinical trials
32 drugs studied
Christopher H. LieuUniversity of Colorado Hospital4 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
10 reported clinical trials
39 drugs studied
Clinical Trials running at UCHealth Highlands Ranch Hospital
Breast Cancer
Prostate Cancer
Rectal Cancer
Urothelial Carcinoma
Cancer
Bladder Cancer
Colon Cancer
Lung Cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UCHealth Highlands Ranch Hospital?
UCHealth Highlands Ranch Hospital is a medical facility located in Littleton, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. UCHealth Highlands Ranch Hospital is involved with conducting 45 clinical trials across 78 conditions. There are 23 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Anthony D Elias, M.D., and Christopher H. Lieu.